Results 31 to 40 of about 172,098 (309)

Exploring the interdependencies of research funders in the UK [PDF]

open access: yes, 2014
Investment in medical research is vital to the continuing improvement of the UK's health and wealth. It is through research that we expand our understanding of disease and develop new treatments for patients.
Crane, P   +13 more
core   +1 more source

Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer

open access: yesBMC Cancer, 2018
Background Paclitaxel induced peripheral neuropathy (PIPN) is a major debilitating side effect of paclitaxel in patients with breast cancer with no fully known mechanisms. The aim of the study was to find out the possible risk factors for PIPN.
Zohreh Ghoreishi   +5 more
doaj   +1 more source

The substrate of the biopsychosocial influences in the carcinogenesis of the digestive tract [PDF]

open access: yes, 2016
Digestive cancer represents a severe public health problem, being one of the main causes of death. It is considered a multifactorial disease, with hereditary predisposition, environmental factors, and other factors involved in carcinogenesis.
Caragea, Daniel   +5 more
core   +3 more sources

Neoplastic Parkinsonism: An illustrative case report

open access: yesAnnals of Indian Academy of Neurology, 2013
Non-Hodgkin′s lymphoma of T-cell types are rare neoplasms. Central nervous system metastasis is unusual. We are reporting a patient with peripheral T-cell lymphoma unspecified who had extra nodal metastasis into the brain that manifested with ...
Lekha Pandit   +4 more
doaj   +1 more source

Somatostatin and Its Receptor System in Colorectal Cancer

open access: yesBiomedicines, 2021
Somatostatin (SST)/somatotropin release-inhibiting factor (SRIF) is a well-known neuropeptide, widely distributed in the central and peripheral nervous systems, that regulates the endocrine system and affects neurotransmission via interaction with five ...
Aldona Kasprzak
doaj   +1 more source

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms [PDF]

open access: yes, 2018
We analyzed 597 patients with myeloproliferative neoplasms (MPN) who presented transient ischemic attacks (TIA, n = 270) or ischemic stroke (IS, n = 327). Treatment included aspirin, oral anticoagulants, and cytoreductive drugs.
Arellano-Rodrigo, Eduardo   +41 more
core   +5 more sources

The GDNF Family: A Role in Cancer?

open access: yesNeoplasia: An International Journal for Oncology Research, 2018
The glial cell line–derived neurotrophic factor (GDNF) family of ligands (GFLs) comprising of GDNF, neurturin, artemin, and persephin plays an important role in the development and maintenance of the central and peripheral nervous system, renal ...
Graeme C. Fielder   +7 more
doaj   +1 more source

Pancreatic exocrine insufficiency after bariatric surgery [PDF]

open access: yes, 2017
Morbid obesity is a lifelong disease, and all patients require complementary follow-up including nutritional surveillance by a multidisciplinary team after bariatric procedures.
Arnelo, Urban   +7 more
core   +1 more source

Diagnostic Pathology of Tumors of Peripheral Nerve.

open access: yesNeurosurgery, 2021
Neoplasms of the peripheral nervous system represent a heterogenous group with a wide spectrum of morphological features and biological potential. They range from benign and curable by complete excision (schwannoma and soft tissue perineurioma) to benign
Sarra Belakhoua, F. Rodriguez
semanticscholar   +1 more source

Increased CD16a (FcγRIIIA) Expression in The Tumor Microenvironment of Atypical Neurofibromatous Neoplasms of Uncertain Biologic Potential May Be Associated with Progression from Neurofibromas to Atypical Neurofibromas

open access: yesJournal of Personalized Medicine, 2023
Neurofibroma (NF) is a benign tumor in the peripheral nervous system, but it can infiltrate around structures and cause functional impairment and disfigurement.
M. Yeo   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy